Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2026	Dec. 31, 2025
ASSETS
Cash and cash equivalents	$ 209,686	$ 97,929
Restricted cash	14,641	14,517
Accounts receivable, net of credit loss reserve of $4,705 and $4,506, respectively	479,800	446,224
Prepaid expenses and other current assets	36,857	49,904
Assets held for sale	2,513	2,513
Total current assets	743,497	611,087
Real estate and related assets:
Property and equipment, net of accumulated depreciation of $2,041,487 and $2,012,353, respectively	2,122,430	2,132,206
Other real estate assets	180,148	182,479
Goodwill	8,551	8,551
Other assets	313,369	322,420
Total assets	3,367,995	3,256,743
LIABILITIES AND STOCKHOLDERS' EQUITY
Accounts payable and accrued expenses	288,362	353,173
Current portion of long-term debt	16,611	15,701
Total current liabilities	304,973	368,874
Long-term debt, net	1,380,955	1,205,037
Deferred revenue	7,812	8,719
Non-current deferred tax liabilities	111,297	98,364
Other liabilities	167,348	170,500
Total liabilities	1,972,385	1,851,494
Commitments and contingencies
Preferred stock - $0.01 par value; 50,000 shares authorized; none issued and outstanding at March 31, 2026 and December 31, 2025	0	0
Common stock - $0.01 par value; 300,000 shares authorized; 98,887 and 100,051 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively	989	1,001
Additional paid-in capital	1,480,181	1,527,724
Accumulated deficit	(85,560)	(123,476)
Total stockholders' equity	1,395,610	1,405,249
Total liabilities and stockholders' equity	$ 3,367,995	$ 3,256,743